Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
33525
- Development stage
- Preclinical
- Lead developer
- Valeant Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
33525 is a topical antifungal cream developed by Medicis Global Service Corporation. It is being investigated for its safety and efficacy in the treatment of tinea pedis (athlete's foot) and tinea cruris (jock itch).
- Other names
- Product 33525Product33525Product-33525
02
Targets
CYP51A1 (Sterol 14α-demethylase)
Beyond the preview
Go deeper on 33525.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 33525.